US May Revise Drug Tariffs, Trump Likely to Announce in Coming Days

Washington (The Uttam Hindu): Relief for the pharmaceutical sector as reports suggest that the Trump administration may exclude generic drugs from the 100% tariff imposed on pharma products. After prolonged debate, the administration has indicated that foreign generic drugs may not face additional duties, a decision considered particularly positive for India, a major exporter of generics to the US. The news has already boosted pharma stock prices in the market.

According to a recent Wall Street Journal report, the Trump administration could announce changes to the pharma tariff policy in the coming weeks. The report indicates that generic medicines are likely to be exempted from the tariff, while branded and patented foreign pharma products will remain subject to the 100% duty. The initial tariff announcement had created uncertainty for the global generic drug industry.

With these indications, Indian and other international pharma exporters could see significant benefits. The stock market has reacted positively, with pharma sector shares gaining momentum following the news.